{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:51:34Z","timestamp":1793710294300,"version":"4.6.1"},"reference-count":0,"publisher":"Springer Science and Business Media LLC","issue":"Supplement 4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[1997]]},"DOI":"10.2165\/00003495-199700544-00003","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T19:28:03Z","timestamp":1236194883000},"page":"1-7","source":"Crossref","is-referenced-by-count":366,"title":["Anthrazykline in der Krebstherapie"],"prefix":"10.1007","volume":"54","author":[{"given":"G. N.","family":"Hortob\u00e1gyi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","container-title":["Drugs"],"original-title":[],"language":"en","deposited":{"date-parts":[[2013,1,20]],"date-time":"2013-01-20T09:34:39Z","timestamp":1358674479000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.2165\/00003495-199700544-00003"}},"subtitle":["Ein \u00dcberblick"],"short-title":[],"issued":{"date-parts":[[1997]]},"references-count":0,"journal-issue":{"issue":"Supplement 4"},"URL":"https:\/\/doi.org\/10.2165\/00003495-199700544-00003","relation":{},"ISSN":["0012-6667"],"issn-type":[{"value":"0012-6667","type":"print"}],"subject":[],"published":{"date-parts":[[1997]]}}}